Nutritional Intervention for Endometriosis
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Physicians Committee for Responsible Medicine
- Study ID
- NCT05175248
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Plant-based Intervention Group — BEHAVIORALParticipants in the intervention group will be instructed in ways to adopt a plant-based diet, use appropriate methods of food preparation, and make meals enjoyable and appetizing. The plant-based diet primarily emphasizes whole grains, vegetables, beans and legumes, and fruits. Animal products and added oils will be proscribed and the use of ultra-processed foods, sugar, and sugar-sweetened beverages will be discouraged. Fat intake will be limited to 20-30 g/day.
Study Details
In a 12-week parallel study, women with a verified diagnosis of endometriosis will be randomly assigned to follow a low-fat plant-based diet or to stay on their usual diets for 12 weeks. Participants in both groups will be asked to make no changes to their exercise patterns for the study period. Changes in pain, quality of life, and inflammatory biomarkers from baseline to final will be the primary outcomes. Secondary outcomes will include changes in body weight, blood lipids, gut microbiome composition, and hormonal changes.
Key Dates
- Start date
- Mar 2, 2022
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Plant-based Intervention GroupIntervention group participants will adopt a low-fat, plant-based diet for 12 weeks. Participants will be provided with a commercially available supplement containing 100 micrograms of vitamin B12 and asked to take it daily during the study. Alcoholic beverages will be limited to 1 per day. Participants will be asked to keep their physical activity level constant.
- No Intervention: Control GroupControl group participants will be asked to maintain their usual diet for the duration of the 12-week study period. Participants will be provided with a commercially available supplement containing 100 micrograms of vitamin B12 and asked to take it daily during the study. Alcoholic beverages will be limited to 1 per day. Participants will be asked to keep their physical activity level constant. At the conclusion of the 12 weeks, control group participants will be offered instruction in the plant-based diet.
Primary Outcome Measure
Modified Biberoglu and Behrman Scale: change from baseline [ Time Frame: at baseline and at 12 weeks ]
Central Contacts
- Macy Sutton, MS202-527-7385
- Tatiana Znayenko-Miller, DrPH202-527-7317
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Physicians Committee for Responsible Medicine | Washington D.C. | District of Columbia | 20016 | Hana Kahleova, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
By condition
By specialty
Related Studies
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPHASE3 · Recruiting · Sumitomo Pharma Switzerland GmbH · Mobile, Alabama
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruiting · Mayo Clinic · Scottsdale, Arizona
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin